EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

USP34 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes

Helena Wigoda, Amjad Khan iD, Bryce A Mendelsohn iD, Noriko Miyake, Nobuhiko Okamoto, Naomichi Matsumoto iD, Patricia J C Knijnenburg, Johanna M van Hagen, Jiddeke van de Kamp, Quinten Waisfisz, Bryn D Webb iD

Clinical Genetics · 2026-09 · 110 (3) · 315-324

DOI: 10.1111/cge.70194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 18.06.2026. Verfasst von Helena Wigoda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Center for Precision Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Haploinsufficiency, Neurodevelopmental Disorders, Ubiquitin-Specific Proteases. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Wisconsin School of Medicine and Public Health Center for Precision Medicine, University of Wisconsin School of Medicine and Public Health Department of Pediatrics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 2p15p16.1 microdeletion syndrome is a rare neurodevelopmental disorder caused by heterozygous deletions of variable size involving multiple dosage‐sensitive genes. Within the narrowed critical interval, USP34 has emerged as a particularly strong candidate for the core phenotype, supported by reports of smaller deletions involving only USP34 and XPO1 , and by the fact that USP34 encodes a deubiquitinating enzyme that stabilizes Axin and thereby regulates canonical Wnt/β‐catenin signaling, a pathway critical for neurodevelopment, craniofacial morphogenesis, and limb patterning. We report six individuals with heterozygous loss‐of‐function variants in USP34 , including five with confirmed de novo variants, associated with global developmental delay, craniofacial dysmorphism, marked speech impairment, variable autism spectrum disorder, and distal limb anomalies. The phenotype associated with isolated loss of USP34 overlaps substantially with that reported in 2p15p16.1 microdeletion syndrome, while suggesting that some features seen in larger deletions may reflect the contribution of additional genes within the interval. These findings support haploinsufficiency of USP34 as sufficient to cause a distinct neurodevelopmental disorder, establish USP34 as a major contributor to the neurodevelopmental and dysmorphic phenotype associated with the 2p15p16.1 locus, and refine gene‐specific contributions within this microdeletion syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HaploinsufficiencyNeurodevelopmental DisordersUbiquitin-Specific ProteasesHumansPhenotypeFemaleMaleChromosome DeletionChildChromosomes, Human, Pair 2NeurodevelopmentChild, PreschoolDevelopmental DisabilitiesGenetic Association Studies

Stichwörter der Autor:innen

2p15p16.1 microdeletion syndromeUSP34autism spectrum disorderdevelopmental delayneurodevelopmental disorder

Substanzen

Ubiquitin-Specific ProteasesUSP34 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Center for Precision Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
  • Department of Zoology, Institute of Biological Sciences, University of Lakki Marwat, Lakki Marwat, Khyber Pakhtunkhwa, Pakistan.
  • Department of Medical Genetics, Kaiser Permanente Oakland Medical Center, Oakland, California, USA.
  • Department of Pediatrics, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan.
  • Department of Medical Genetics, Osaka Women's and Children's Hospital, Izumi, Osaka, Japan.
  • Department of Human Genetics, Graduate School of Medicine, Yokohama City University, Yokohama, Japan.

ORCID-Profile: Amjad Khan, Bryce A Mendelsohn, Naomichi Matsumoto, Bryn D Webb

Förderung

  • University of Wisconsin School of Medicine and Public Health Center for Precision Medicine
  • University of Wisconsin School of Medicine and Public Health Department of Pediatrics

Zitieren

APA

Wigoda, H., Khan, A., Mendelsohn, B. A., Miyake, N., Okamoto, N., Matsumoto, N., Knijnenburg, P. J. C., van Hagen, J. M., van de Kamp, J., Waisfisz, Q., & Webb, B. D. (2026). USP34 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes. Clinical Genetics, 110(3), 315-324. https://doi.org/10.1111/cge.70194

Vancouver

Wigoda H, Khan A, Mendelsohn BA, Miyake N, Okamoto N, Matsumoto N, et al. USP34 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes. Clinical Genetics. 2026;110(3):315-324. doi:10.1111/cge.70194

BibTeX
@article{Wigoda2026,
  author = {Wigoda, Helena and Khan, Amjad and Mendelsohn, Bryce A and Miyake, Noriko and Okamoto, Nobuhiko and Matsumoto, Naomichi and Knijnenburg, Patricia J C and van Hagen, Johanna M and van de Kamp, Jiddeke and Waisfisz, Quinten and Webb, Bryn D},
  title = {USP34 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes},
  journal = {Clinical Genetics},
  year = {2026},
  volume = {110},
  number = {3},
  pages = {315--324},
  doi = {10.1111/cge.70194}
}
Kostenlos starten →